CytomX Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $5.3M | $3.0M | $2.3M | $14.8M |
| FY2021 | $-119.0M | $-120.6M | $1.6M | $13.2M |
| FY2022 | $-110.8M | $-112.5M | $1.7M | $13.1M |
| FY2023 | $-56.0M | $-56.9M | $840.0K | $8.6M |
| FY2024 | $-86.2M | $-86.5M | $310.0K | $7.7M |